Xiaofen Zhong

Title: Innovations of Xiaofen Zhong in Neurotoxin Research

Introduction

Xiaofen Zhong is a prominent inventor based in Guangzhou, China. She has made significant contributions to the field of neurotoxin research, particularly through her innovative work involving genes derived from sea snake venom. Her research has implications for pain management and therapeutic applications.

Latest Patents

Xiaofen Zhong holds a patent that focuses on three genes encoding short chain neurotoxins, obtained through the construction of a cDNA library from sea snake venom glands and subsequent DNA sequencing. The genes are named sn12, sn36, and sn160. These genes are modified and amplified using the PCR method and cloned into the expression vector PETTRX. The neurotoxin genes are expressed in soluble fusion protein in the BL21-DE3 strain, which serves as the expression host when induced with IPTG. Studies on the analgesic effects of these recombinant short chain neurotoxins have demonstrated that all three proteins, SN12, SN36, and SN160, significantly increase the pain threshold value in mice.

Career Highlights

Xiaofen Zhong is affiliated with Zhongshan University, where she continues her research and development in neurotoxin applications. Her work has garnered attention for its potential to advance pain relief methods.

Collaborations

Xiaofen collaborates with notable colleagues, including Anlong Xu and Lisheng Peng, who contribute to her research endeavors.

Conclusion

Xiaofen Zhong's innovative research in neurotoxin development showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact pain management therapies in the future.